Cited 50 times in
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.